English
Home > Products > 144284-24-2

China 144284-24-2 Factory

With our abundant experience and considerate products and services, we have been recognized to be a reputable supplier for a lot of global consumers for 144284-24-2,CAS NO 144284-24-2,2,3,4-Trifluorobenzyl alcohol, Our workforce members are intention to provides products and solutions with large performance cost ratio to our shoppers, as well as the goal for all of us would be to satisfy our consumers from everywhere in the globe.
144284-24-2, We adopted technique and quality system management, based on "customer orientated, reputation first, mutual benefit, develop with joint efforts", welcome friends to communicate and cooperate from all over the world.

Related Products

Hot Products

  • Eldecalcitol Intermediate A

    Eldecalcitol Intermediate A

    Product Name:Eldecalcitol Intermediate A
    Molecular Formula:C42H71O5PSi3
    Molecular Weight:771.24
    CAS Registry Number:200636-54-0
  • Flumethasone

    Flumethasone

    Product Name:Flumethasone
    Molecular Formula:C22H28F2O5
    Molecular Weight:410.45
    CAS Registry Number;2135-17-3
  • 5-Amino-2-methoxypyridine

    5-Amino-2-methoxypyridine

    Product Name:5-Amino-2-methoxypyridine
    Molecular Formula:C6H8N2O
    Molecular Weight:124.14
    CAS Registry Number:6628-77-9
  • Agomelatine

    Agomelatine

    Product Name:Agomelatine
    Molecular Formula:C15H17NO2
    Molecular Weight;243.3
    CAS Registry Number;138112-76-2
  • Trimebutine maleate

    Trimebutine maleate

    Product Name:Trimebutine maleate
    Molecular Formula:C26H33NO9
    Molecular Weight;503.54
    CAS Registry Number;34140-59-5
  • 2,4-Difluorobenzaldehyde

    2,4-Difluorobenzaldehyde

    Product Name:2,4-Difluorobenzaldehyde
    Molecular Formula:C7H4F2O
    Molecular Weight:142.1
    CAS Registry Number:1550-35-2
  • Related Blog
  • Reviews

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Related Search

CAS NO 144284-24-2

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept